semaglutide gi obstruction lawsuit in michigan digestive blockage class action gastrointestinal Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) filed against semaglutide digestive blockage legal team

Dietary supplements are not well regulated and may cause a positive drug test result

The GLP-1 agonist, exenatide, increased fasting EF via endothelial nitric oxide (NO) synthase (eNOS) activation, nitric oxide (NO) production in endothelial cells, induced dose-dependent vasorelaxation, and reduced high-glucose or lipid-induced endothelial dysfunction in arterioles ex vivo [64]

Q8: How long do I need to stay on the 0.25mg starter dose

They may recommend pausing at your current dose, delaying the next escalation, or exploring alternative medicationssuch as compounded tirzepatide or a different GLP-1 formulationthat may carry different side effect profiles for your individual case